Real-world Clinical Efficacy of Abatacept in the T3 Data Registry

• Status: Completed
• Trial end date: 2016-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the effectiveness of Abatacept in real-world clinical practice. The main hypothesis to be examined in this study is, "Abatacept's effectiveness results in a single real-world clinic (n = 100) are reproducible at another site (n ~= 200)".

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Arthritis Northwest PLLC
• Collaborator: Bristol-Myers Squibb
• Treatments: Abatacept

Criteria

Inclusion Criteria:

• Diagnosed with rheumatoid arthritis

• Have used Abatacept for 3 or more months

Exclusion Criteria:

• None